RedHill Biopharma (RDHL) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
RedHill Biopharma Ltd. recently held its Annual General Meeting, with shareholders approving all proposed resolutions. Key decisions include the appointment of Kesselman & Kesselman as auditors for 2024, the re-election of two board members alongside a new member, and the approval of restricted share units for non-executive directors, the CEO, and the Chief Commercial Officer.
For further insights into RDHL stock, check out TipRanks’ Stock Analysis page.
